Sleep Disorders Trial, Recruiting NCT03811964 Sponsor: University Hospital, Strasbourg, France Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT03811964
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • Men or women
  • People who have signed a free and informed consent form
  • People who are part of a social protection scheme (such as health insurance or social security coverage)
  • People in one of the following groups: those with a primary sleep-wake disorder; those with a neurological condition that affects sleep and wakefulness; those with a psychiatric condition that affects sleep and wakefulness; those with an eye condition that may affect how light is received or processed by the eye; those with light sensitivity that affects sleep and wake regulation; or healthy individuals with no relevant conditions

Who may not be able to join:

  • People with Age-Related Macular Degeneration (AMD) or similar conditions affecting the retina, such as retinitis pigmentosa or diabetes-related damage to the eye
  • People with cataracts that have caused significant vision loss (below 5/10 vision)
  • People with abnormal blood vessel growth behind the retina (confirm with trial site)
  • People who are currently in an exclusion period due to participation in another study
  • People for whom it is not possible to provide proper informed consent, such as those in an emergency situation or those who have difficulty understanding the information
  • People who are under the protection of the justice system
  • People who are under guardianship or supervised legal protection
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bourgin Patrice, MD, University Hospital, Strasbourg, France

Phone: 03 88 11 64 30

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 January 2020
Est. completion
1 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

PIPR : Post-Illumination Pupil Response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov